MoneyWeek

MoneyWeek’s comprehensive guide to this week’s share tips

Three to buy

Indivior

The Sunday Times

n 2019 Indivior was charged in the US with running an “illicit nationwide scheme to increase prescriptions” of a version of its opioid-addiction treatment. But the drugmaker seems to have redeemed itself. It has invested in a new treatment for cannabis-related disorders, branched out into alcohol-misuse drugs and grown sales of its injection for opioid addiction. But the stock is still selling for half its 2018 price. Sales

You’re reading a preview, subscribe to read more.

More from MoneyWeek

MoneyWeek1 min read
Revive The Spirit Of 1994
unherd.com It has been 30 years since the opening of the Channel Tunnel rail link between Britain and the European continent, says Jonathan Glancey. “Politically, technically, financially and culturally”, the “chunnel” was a “profound achievement”.
MoneyWeek2 min read
The Inexorable Rise Of India
The relentless focus on the tech sector means you could be forgiven for thinking the US has been by far the top-performing stockmarket in the last few years – but it’s not. While America has done extremely well, there are a handful of countries beati
MoneyWeek1 min read
Petty Cash... Time To Switch
● The poor savings rates offered by the six big banks mean small firms are missing out on more than £200m of interest each month on their deposits. The big banks dominate the market for business savings accounts in the UK, but rarely pay competitive

Related Books & Audiobooks